Metacrine Appoints Pharmaceutical Business and R&D Executive, Preston Klassen, M.D., MHS, as President and Chief Executive Officer


You May Also Like

ZIOPHARM to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

BOSTON, Sept. 05, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that ...

MDxHealth: SelectMDx Study Demonstrates Cost-effectiveness in US Healthcare System

NEWS RELEASE  REGULATED INFORMATION                                                                                                                    Data published in Journal of Urology reports over ...